Carglumic Acid Market
Carglumic Acid Market Analysis by Dispersible Tablets and Orally Disintegrating Tablets from 2023 to 2033
Analysis of Carglumic Acid Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Carglumic Acid Market Growth Outlook (2023 to 2033)
Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033.
Carglumic acid is derived from N-acetyl glutamate which helps in the removal of ammonia and detoxification by activating the first enzyme in the urea cycle. This drug is particularly used for the treatment of rare diseases such as propionic academia and methyl-malonic academia which are autosomal recessive disease and often requires lifelong medical treatment to maintain normal well-being.
| Report Attributes | Details |
|---|---|
| Carglumic Acid Market Size (2022A) | US$ 141.9 Million |
| Estimated Market Value (2023E) | US$ 152.5 Million |
| Forecasted Market Value (2033F) | US$ 314.4 Million |
| Global Market Growth Rate (2023 to 2033) | 7.5% CAGR |
| North America Market Share (2022) | 40.9% |
| Key Companies Profiled | Apothecon Pharmaceuticals Pvt Ltd.; Manus Aktteva Biopharma LLP; Civentichem LLC; Dipharma Francis S.r.l; Recordati Rare Diseases |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Historic to Future Path of Carglumic Acid Market
Carglumic acid is used for therapeutic treatment that enhances the quality of life, and as a result, the market for therapeutic drugs is expected to rise significantly between 2023 and 2033. Manufacturers are emphasizing on developing new formulations of carglumic acid to manage life-threatening, rare congenital metabolic disorders that result in ammonia deficiency in humans.
A sedentary lifestyle, rising alcohol consumption, and smoking-related diseases to further enhance the demand for carglumic acid as these habits result in the accumulation of ammonia in the blood.
- Growth Factors for Short Term (2023 to 2026): The rise of cancers brought on by alcohol, tobacco, and inactivity, as well as the rise of metabolic diseases like cirrhosis, Reye's syndrome, and hepatic encephalopathy globally, are the main factors propelling the growth of the carglumic acid market.
- Factors for Medium-Term Growth (2026 to 2029): Carglumic acid has the potential to promote apoptosis and speed up the suppression of cancer cells in a variety of cancers, including pancreatic ductal adenocarcinoma and lung cancer.
- Long-Term Growth Opportunities (2029 to 2033): Efforts led by market players to curb the demand pool and gain high-profit margins are likely to drive the carglumic acid market.
According to Fact.MR, the market for carglumic acid has grown at a CAGR of 4.8% from 2018 to 2022 and is expected to grow at a CAGR of 7.5% from 2023 to 2033.
Factor’s Contributing to the Expansion of the Carglumic Acid Market
“Apoptosis and Cancer Cell Suppression Are Potential Benefits of Carglumic Acid”
Drug repurposing has remained a popular therapeutic strategy, which applies to drug development for the treatment of multiple diseases on the basis of new therapeutic functions.
Carglumic acid has grown in popularity as a result of its versatility in treating a variety of diseases, including hyperammonemia, and cancer. The chemical is also used to prevent ammonia intoxication, promote apoptosis in cancer cells, avoid brain injury, and more.
Repurposing carglumic acid as an anti-cancer agent has depicted its potential in inhibiting cancer cell proliferation and inducing apoptosis in various cancers, including lung cancer, hepatoma, triple-negative breast cancer (TNBC), and pancreatic ductal adenocarcinoma. The usage of this orphan medicine is currently gaining enormous traction in the treatment of patients with hyperammonemia, a rare congenital condition brought on by urea cycle enzyme-related genetic abnormalities.
“Carglumic Acid Market to Reach Substantial Revenues Due to Exome Sequencing System Development”
The global prevalence of metabolic disorders such as cirrhosis, Reye's illness, and hepatic encephalopathy, as well as rising alcohol consumption, smoking, and sedentary lifestyles that induce different cancers are the main drivers of the carglumic acid market.
This increases the appeal for treatment by increasing the amount of smelling salts in the blood. Moreover, carglumic acid has demonstrated potential for inhibiting tumor growth in breast cancer, in addition to other uses in cosmetics and synthetics, which are anticipated to drive the global carglumic acid market throughout the anticipated time period.
The development of the "whole exome sequencing" procedure is being pursued by scientists worldwide, with the goal of preventing intellectual disability in children by combining genomic sequencing with metabolomics research of carglumic acid. Further applications of carglumic acid include improving ammonia detoxification in patients with organic acidurias.
“Factors Creating a Roadblock for Carglumic Acid Market Growth”
High raw material procurement cost coupled with additional capital investment for final product processing and some side effects related to carglumic acid medications has limited the expansion of carglumic acid use. Additionally, increasing research and development expenditures along with the high cost of medicine has increased the cost of overall production, driving customers to hunt for alternatives.
Additionally, the shelf life of the medicine carglumic acid is less than a month, thus bottles must be thrown away after opening. Over the course of the forecast period, these issues are anticipated to limit the growth of carglumic acid sales.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
What is the Demand Outlook for Carglumic Acid in the U.S.?
The U.S. is anticipated to rule the global market for carglumic acid consumption during the forecast period. The prevalence of breast cancer, lung cancer, and hyperammonemia patients in the United States creates a high demand for carglumic acid in the country.
Additionally, pharmaceutical companies' investments in research to establish novel cancer treatments employing carglumic acid, as well as regulatory agencies like the USFDA initiating campaigns to raise awareness regarding the substance's use and dose in the area, all contribute to the market's expansion.
Moreover, healthcare spending in the U.S. accounts for around 17% of the country’s GDP, thus providing a positive outlook to the market for carglumic acid.
What are the Growth Opportunities for Carglumic Acid Market Across U.K.?
The first medication accepted by the Food and Drug Administration (FDA) for the treatment of NAGS deficiency is Carbaglu (carglumic acid), which was created by Orphan Europe, a major European company in orphan medicine.
One of the most severe disorders affecting people in Europe is NAGS insufficiency, according to experts. Numerous newborns in the area have displayed NAGS deficient signs, necessitating prompt & efficient medical attention to restore elevated ammonium levels to normal.
The U.K. carglumic market is expected to grow at a CAGR of 7.2% and offer an absolute dollar opportunity worth US$ 16.4 million during the forecast period as a result of the aforementioned factors.
Category-wise Insights
Why Consumption of Oral Dispersible Tablets Stimulates Market Growth?
The dispersible tablets segment holds a prominent share in the market as carbaglu oral dispersible tablet is the only approved drug. The dispersible tablets dissolve instantly in water or in the mouth. Patients having trouble swallowing traditional dosage forms, such as children, stroke patients, and the elderly benefit from the tablets' speedy administration.
Furthermore, the increased cost of the tablets is anticipated to result in their greatest revenue, which will support the market for the foreseeable future.
Which Distribution Channel is Projected to Bolster Carglumic Acid Market Growth?
Hospital pharmacies account for around half of the total carglumic acid market. This is mostly attributable to established hospital infrastructure, quick access to medications, patient convenience, preference for the purchase of medications, and the simplicity and dependability of pharmacy outlets.
Owing to the above-mentioned factors, the hospital pharmacies are set to grow during the projected period creating an absolute $ opportunity of US$ 67.2 million between 2023 to 2033.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Strategies by Manufacturers
Prominent carglumic acid manufacturers are Apothecon Pharmaceuticals Pvt Ltd, Manus Aktteva Biopharma LLP, Civentichem LLC, Dipharma Francis S.r.l, Recordati Rare Diseases, and many more.
The global market for carglumic acid has a few significant competitors and is moderately competitive. A few of the major players are now leading the market in terms of sales and are employing a variety of techniques, such as acquiring other businesses to strengthen their market positions globally.
Numerous players are focusing on getting approval for generic products. For instance, the growth of API producers like Suven and Apothecan in India creates income by delivering the API to satisfy the need for carglumic acid, which propels the market growth.
- In December 2021, ANI Pharmaceuticals and Eton Pharmaceuticals announced the commercial availability of carglumic acid tablets. The drug is the first and only generic version of Carbaglu that is approved by the FDA. The FDA gave it the go-ahead to treat acute and chronic hyperammonemia brought on by a lack of N-acetyl glutamate synthase (NAGS).
Fact.MR has provided detailed information about the price points of key manufacturers of carglumic acid positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Segmentation of Carglumic Acid Market
-
By Dosage :
- Dispersible Tablets
- Oral Disintegrating Tablets
- Others
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Market - Executive Summary
- 2. Market Overview
- 3. Market Background and Foundation Data
- 4. Global Demand (Tons) Analysis and Forecast
- 5. Global Market - Pricing Analysis
- 6. Global Market Value (US$ million) Analysis and Forecast
- 7. Global Market Analysis and Forecast, By Dosage
- 7.1. Dispersible Tablets
- 7.2. Oral Disintegrating Tablets
- 7.3. Others
- 8. Global Market Analysis and Forecast, By Distribution Channel
- 8.1. Hospital Pharmacies
- 8.2. Retail Pharmacies
- 8.3. E-Commerce
- 9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East & Africa
- 10. North America Market Analysis and Forecast
- 11. Latin America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia & Oceania Market Analysis and Forecast
- 15. Middle East & Africa Market Analysis and Forecast
- 16. Country-level Market Analysis and Forecast
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1. Apothecon Pharmaceuticals Pvt Ltd
- 18.2. Manus Aktteva Biopharma LLP
- 18.3. Civentichem LLC
- 18.4. Dipharma Francis S.r.l
- 18.5. Phillips Limited
- 18.6. Recordati Rare Diseases
- 18.7. Other Prominent Players
- 19. Assumptions & Acronyms Used
- 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01. Global Market Value (US$ million) By Region, 2018 to 2022
Table 02. Global Market Value (US$ million) and Forecast By Region, 2023 to 2033
Table 03. Global Market Volume (Tons) By Region, 2018 to 2022
Table 04. Global Market Volume (Tons) and Forecast By Region, 2023 to 2033
Table 05. Global Market Value (US$ million), By Dosage, 2018 to 2022
Table 06. Global Market Value (US$ million) and Forecast By Dosage, 2023 to 2033
Table 07. Global Market Volume (Tons), By Dosage, 2018 to 2022
Table 08. Global Market Volume (Tons) and Forecast By Dosage, 2023 to 2033
Table 09. Global Market Value (US$ million), By Distribution Channel, 2018 to 2022
Table 10. Global Market Value (US$ million) and Forecast By Distribution Channel, 2023 to 2033
Table 11. Global Market Volume (Tons), By Distribution Channel, 2018 to 2022
Table 12. Global Market Volume (Tons) and Forecast By Distribution Channel, 2023 to 2033
Table 13. North America Market Value (US$ million), By Country, 2018 to 2022
Table 14. North America Market Value (US$ million) and Forecast By Country, 2023 to 2033
Table 15. North America Market Volume (Tons), By Country, 2018 to 2022
Table 16. North America Market Volume (Tons) and Forecast By Country, 2023 to 2033
Table 17. North America Market Value (US$ million), By Dosage, 2018 to 2022
Table 18. North America Market Value (US$ million) and Forecast By Dosage, 2023 to 2033
Table 19. North America Market Volume (Tons), By Dosage, 2018 to 2022
Table 20. North America Market Volume (Tons) and Forecast By Dosage, 2023 to 2033
Table 21. North America Market Value (US$ million), By Distribution Channel, 2018 to 2022
Table 22. North America Market Value (US$ million) and Forecast By Distribution Channel, 2023 to 2033
Table 23. North America Market Volume (Tons), By Distribution Channel, 2018 to 2022
Table 24. North America Market Volume (Tons) and Forecast By Distribution Channel, 2023 to 2033
Table 25. Latin America Market Value (US$ million), By Country, 2018 to 2022
Table 26. Latin America Market Value (US$ million) and Forecast By Country, 2023 to 2033
Table 27. Latin America Market Volume (Tons), By Country, 2018 to 2022
Table 28. Latin America Market Volume (Tons) and Forecast By Country, 2023 to 2033
Table 29. Latin America Market Value (US$ million), By Dosage, 2018 to 2022
Table 30. Latin America Market Value (US$ million) and Forecast By Dosage, 2023 to 2033
Table 31. Latin America Market Volume (Tons), By Dosage, 2018 to 2022
Table 32. Latin America Market Volume (Tons) and Forecast By Dosage, 2023 to 2033
Table 33. Latin America Market Value (US$ million), By Distribution Channel, 2018 to 2022
Table 34. Latin America Market Value (US$ million) and Forecast By Distribution Channel, 2023 to 2033
Table 35. Latin America Market Volume (Tons), By Distribution Channel, 2018 to 2022
Table 36. Latin America Market Volume (Tons) and Forecast By Distribution Channel, 2023 to 2033
Table 37. Europe Market Value (US$ million), By Country, 2018 to 2022
Table 38. Europe Market Value (US$ million) and Forecast By Country, 2023 to 2033
Table 39. Europe Market Volume (Tons), By Country, 2018 to 2022
Table 40. Europe Market Volume (Tons) and Forecast By Country, 2023 to 2033
Table 41. Europe Market Value (US$ million), By Dosage, 2018 to 2022
Table 42. Europe Market Value (US$ million) and Forecast By Dosage, 2023 to 2033
Table 43. Europe Market Volume (Tons), By Dosage, 2018 to 2022
Table 44. Europe Market Volume (Tons) and Forecast By Dosage, 2023 to 2033
Table 45. Europe Market Value (US$ million), By Distribution Channel, 2018 to 2022
Table 46. Europe Market Value (US$ million) and Forecast By Distribution Channel, 2023 to 2033
Table 47. Europe Market Volume (Tons), By Distribution Channel, 2018 to 2022
Table 48. Europe Market Volume (Tons) and Forecast By Distribution Channel, 2023 to 2033
Table 49. East Asia Market Value (US$ million), By Country, 2018 to 2022
Table 50. East Asia Market Value (US$ million) and Forecast By Country, 2023 to 2033
Table 51. East Asia Market Volume (Tons), By Country, 2018 to 2022
Table 52. East Asia Market Volume (Tons) and Forecast By Country, 2023 to 2033
Table 53. East Asia Market Value (US$ million), By Dosage, 2018 to 2022
Table 54. East Asia Market Value (US$ million) and Forecast By Dosage, 2023 to 2033
Table 55. East Asia Market Volume (Tons), By Dosage, 2018 to 2022
Table 56. East Asia Market Volume (Tons) and Forecast By Dosage, 2023 to 2033
Table 57. East Asia Market Value (US$ million), By Distribution Channel, 2018 to 2022
Table 58. East Asia Market Value (US$ million) and Forecast By Distribution Channel, 2023 to 2033
Table 59. East Asia Market Volume (Tons), By Distribution Channel, 2018 to 2022
Table 60. East Asia Market Volume (Tons) and Forecast By Distribution Channel, 2023 to 2033
Table 61. South Asia & Oceania Market Value (US$ million), By Country, 2018 to 2022
Table 62. South Asia & Oceania Market Value (US$ million) and Forecast By Country, 2023 to 2033
Table 63. South Asia & Oceania Market Volume (Tons), By Country, 2018 to 2022
Table 64. South Asia & Oceania Market Volume (Tons) and Forecast By Country, 2023 to 2033
Table 65. South Asia & Oceania Market Value (US$ million), By Dosage, 2018 to 2022
Table 66. South Asia & Oceania Market Value (US$ million) and Forecast By Dosage, 2023 to 2033
Table 67. South Asia & Oceania Market Volume (Tons), By Dosage, 2018 to 2022
Table 68. South Asia & Oceania Market Volume (Tons) and Forecast By Dosage, 2023 to 2033
Table 69. South Asia & Oceania Market Value (US$ million), By Distribution Channel, 2018 to 2022
Table 70. South Asia & Oceania Market Value (US$ million) and Forecast By Distribution Channel, 2023 to 2033
Table 71. South Asia & Oceania Market Volume (Tons), By Distribution Channel, 2018 to 2022
Table 72. South Asia & Oceania Market Volume (Tons) and Forecast By Distribution Channel, 2023 to 2033
Table 73. MEA Market Value (US$ million), By Country, 2018 to 2022
Table 74. MEA Market Value (US$ million) and Forecast By Country, 2023 to 2033
Table 75. MEA Market Volume (Tons), By Country, 2018 to 2022
Table 76. MEA Market Volume (Tons) and Forecast By Country, 2023 to 2033
Table 77. MEA Market Value (US$ million), By Dosage, 2018 to 2022
Table 78. MEA Market Value (US$ million) and Forecast By Dosage, 2023 to 2033
Table 79. MEA Market Volume (Tons), By Dosage, 2018 to 2022
Table 80. MEA Market Volume (Tons) and Forecast By Dosage, 2023 to 2033
Table 81. MEA Market Value (US$ million), By Distribution Channel, 2018 to 2022
Table 82. MEA Market Value (US$ million) and Forecast By Distribution Channel, 2023 to 2033
Table 83. MEA Market Volume (Tons), By Distribution Channel, 2018 to 2022
Table 84. MEA Market Volume (Tons) and Forecast By Distribution Channel, 2023 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01. Global Market Value (US$ million) and Volume (Tons) Forecast, 2023 to 2033
Figure 02. Global Market Absolute $ Opportunity (US$ million), 2023 to 2033
Figure 03. Global Market Value (US$ million) and Volume (Tons) By Region, 2023 & 2033
Figure 04. Global Market Y-o-Y Growth Rate By Region, 2023 to 2033
Figure 05. Global Market Value (US$ million) and Volume (Tons) By Dosage, 2023 & 2033
Figure 06. Global Market Y-o-Y Growth Rate By Dosage, 2023 to 2033
Figure 07. Global Market Value (US$ million) and Volume (Tons) By Distribution Channel, 2023 & 2033
Figure 08. Global Market Y-o-Y Growth Rate By Distribution Channel, 2023 to 2033
Figure 09. North America Market Value (US$ million) and Volume (Tons) Forecast, 2023 to 2033
Figure 10. North America Market Absolute $ Opportunity (US$ million), 2023 to 2033
Figure 11. North America Market Value (US$ million) and Volume (Tons), By Country, 2023 & 2033
Figure 12. North America Market Y-o-Y Growth Rate By Country, 2023 to 2033
Figure 13. North America Market Value (US$ million) and Volume (Tons) By Dosage, 2023 & 2033
Figure 14. North America Market Y-o-Y Growth Rate By Dosage, 2023 to 2033
Figure 15. North America Market Value (US$ million) and Volume (Tons) By Distribution Channel, 2023 & 2033
Figure 16. North America Market Y-o-Y Growth Rate By Distribution Channel, 2023 to 2033
Figure 17. North America Market Attractiveness Analysis By Country, 2023 to 2033
Figure 18. North America Market Attractiveness Analysis By Dosage, 2023 to 2033
Figure 19. North America Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 20. Latin America Market Value (US$ million) and Volume (Tons) Forecast, 2023 to 2033
Figure 21. Latin America Market Absolute $ Opportunity (US$ million), 2023 to 2033
Figure 22. Latin America Market Value (US$ million) and Volume (Tons), By Country, 2023 & 2033
Figure 23. Latin America Market Y-o-Y Growth Rate By Country, 2023 to 2033
Figure 24. Latin America Market Value (US$ million) and Volume (Tons) By Dosage, 2023 & 2033
Figure 25. Latin America Market Y-o-Y Growth Rate By Dosage, 2023 to 2033
Figure 26. Latin America Market Value (US$ million) and Volume (Tons) By Distribution Channel, 2023 & 2033
Figure 27. Latin America Market Y-o-Y Growth Rate By Distribution Channel, 2023 to 2033
Figure 28. Latin America Market Attractiveness Analysis By Country, 2023 to 2033
Figure 29. Latin America Market Attractiveness Analysis By Dosage, 2023 to 2033
Figure 30. Latin America Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 31. Europe Market Value (US$ million) and Volume (Tons) Forecast, 2023 to 2033
Figure 32. Europe Market Absolute $ Opportunity (US$ million), 2023 to 2033
Figure 33. Europe Market Value (US$ million) and Volume (Tons), By Country, 2023 & 2033
Figure 34. Europe Market Y-o-Y Growth Rate By Country, 2023 to 2033
Figure 35. Europe Market Value (US$ million) and Volume (Tons) By Dosage, 2023 & 2033
Figure 36. Europe Market Y-o-Y Growth Rate By Dosage, 2023 to 2033
Figure 37. Europe Market Value (US$ million) and Volume (Tons) By Distribution Channel, 2023 & 2033
Figure 38. Europe Market Y-o-Y Growth Rate By Distribution Channel, 2023 to 2033
Figure 39. Europe Market Attractiveness Analysis By Country, 2023 to 2033
Figure 40. Europe Market Attractiveness Analysis By Dosage, 2023 to 2033
Figure 41. Europe Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 42. East Asia Market Value (US$ million) and Volume (Tons) Forecast, 2023 to 2033
Figure 43. East Asia Market Absolute $ Opportunity (US$ million), 2023 to 2033
Figure 44. East Asia Market Value (US$ million) and Volume (Tons), By Country, 2023 & 2033
Figure 45. East Asia Market Y-o-Y Growth Rate By Country, 2023 to 2033
Figure 46. East Asia Market Value (US$ million) and Volume (Tons) By Dosage, 2023 & 2033
Figure 47. East Asia Market Y-o-Y Growth Rate By Dosage, 2023 to 2033
Figure 48. East Asia Market Value (US$ million) and Volume (Tons) By Distribution Channel, 2023 & 2033
Figure 49. East Asia Market Y-o-Y Growth Rate By Distribution Channel, 2023 to 2033
Figure 50. East Asia Market Attractiveness Analysis By Country, 2023 to 2033
Figure 51. East Asia Market Attractiveness Analysis By Dosage, 2023 to 2033
Figure 52. East Asia Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 53. South Asia & Oceania Market Value (US$ million) and Volume (Tons) Forecast, 2023 to 2033
Figure 54. South Asia & Oceania Market Absolute $ Opportunity (US$ million), 2023 to 2033
Figure 55. South Asia & Oceania Market Value (US$ million) and Volume (Tons), By Country, 2023 & 2033
Figure 56. South Asia & Oceania Market Y-o-Y Growth Rate By Country, 2023 to 2033
Figure 57. South Asia & Oceania Market Value (US$ million) and Volume (Tons) By Dosage, 2023 & 2033
Figure 58. South Asia & Oceania Market Y-o-Y Growth Rate By Dosage, 2023 to 2033
Figure 59. South Asia & Oceania Market Value (US$ million) and Volume (Tons) By Distribution Channel, 2023 & 2033
Figure 60. South Asia & Oceania Market Y-o-Y Growth Rate By Distribution Channel, 2023 to 2033
Figure 61. South Asia & Oceania Market Attractiveness Analysis By Country, 2023 to 2033
Figure 62. South Asia & Oceania Market Attractiveness Analysis By Dosage, 2023 to 2033
Figure 63. South Asia & Oceania Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 64. MEA Market Value (US$ million) and Volume (Tons) Forecast, 2023 to 2033
Figure 65. MEA Market Absolute $ Opportunity (US$ million), 2023 to 2033
Figure 66. MEA Market Value (US$ million) and Volume (Tons), By Country, 2023 & 2033
Figure 67. MEA Market Y-o-Y Growth Rate By Country, 2023 to 2033
Figure 68. MEA Market Value (US$ million) and Volume (Tons) By Dosage, 2023 & 2033
Figure 69. MEA Market Y-o-Y Growth Rate By Dosage, 2023 to 2033
Figure 70. MEA Market Value (US$ million) and Volume (Tons) By Distribution Channel, 2023 & 2033
Figure 71. MEA Market Y-o-Y Growth Rate By Distribution Channel, 2023 to 2033
Figure 72. MEA Market Attractiveness Analysis By Country, 2023 to 2033
Figure 73. MEA Market Attractiveness Analysis By Dosage, 2023 to 2033
Figure 74. MEA Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What Was the Global Carglumic Acid Market Size Reported by Fact.MR for 2022?
In 2022, the global market for carglumic acid was worth US$ 141.9 million.
What Is the Carglumic Acid Market Size in 2023?
The market is expected to reach a valuation of US$ 152.5 million by 2023.
What is the Projected CAGR for the Carglumic Acid Market from 2023 to 2033?
The market is expected to grow at a CAGR of 7.5% by the end of the forecast period.
What Dosage Type Market Accounts for A Leading Market Share?
Oral disintegrating tablets account for more than 50% of the market share over the other two dosage forms.
Which Region Accounts for the Significant Demand for Carglumic Acid?
North America accounts for more than 40.4% of revenue generated in the global carglumic acid market.
Carglumic Acid Market